Skip to main content Skip to main navigation menu Skip to site footer

Persistence of anti-Salmonella O9 IgM as measured by Tubex® TF may contribute to the over-diagnosis of typhoid fever in endemic areas

  • I Wayan Adi Pranata ,
  • Aly Diana ,
  • Marco R Heryanto ,
  • Nurhayati Lukman ,
  • Herman Kosasih ,
  • Hofiya Djauhari ,
  • Deni PR Butarbutar ,
  • Susana Widjaja ,
  • Bachti Alisjahbana ,


Abstract

Background: Diagnosing typhoid fever definitively, using bone-marrow, blood or feces culture is either invasive, time-consuming, expensive, or complicated. Hence, clinicians often use clinical presentations and/or rapid diagnostic methods to examine the indirect evidence of Salmonella typhi infections. This study describes the proportion of typhoid fever, challenges of diagnosing typhoid fever, and the kinetics of anti-Salmonella O9 IgM.

Methods: During a prospective dengue study in Bandung, Indonesia, 1,431 febrile occurrences were observed among 2,978 adult volunteers over a four-year period. As typhoid fever is endemic and represents a major cause of febrile illness in this study area, acute- and convalescent-phase sera from 964 subjects that had been excluded for dengue and chikungunya infections, were tested with Tubex® TF. To observe the kinetics of anti-Salmonella O9 IgM, we tested sequential sera up to 260 days post-illness from 3 subjects.  

Results: Based on Tubex® TF, 71 of 964 (7.4%) subjects had anti-Salmonella O9 IgM (score≥4) in their convalescent sera. Anti-Salmonella O9 IgM scores in convalescent sera increased compared to the acute sera in 36 subjects, indicating probable acute typhoid fever. The convalescent scores decreased/remained the same as acute sera in the other 35 subjects, which more likely indicating previous S. typhi infections. Using serially collected sera, it was determined that anti-Salmonella O9 IgM could be detected for a long period after illness.

Conclusion: Tubex® TF test should be conducted using paired acute- and convalescent-phase sera to reduce the chance of false positive result that may due to long-lasting anti-Salmonella O9 IgM.

Keywords: persistence typhoid fever Tubex® TF Indonesia

References

  1. World Health Organization. Guidelines for the Management of Typhoid Fever. Geneva: World Health Organization; 2011.
  2. Parry CM, Hien TT, Dougan GG, White NJ, Farrar JJ. Typhoid fever. N Engl J Med. 2002; 347: 1770–1782.
  3. Crump JA. Progress in Typhoid Fever Epidemiology. Clin Infect Dis. 2019; 68(Suppl 1): S4-S9
  4. Baker S, Favorov M, Dougan G. Searching for the elusive typhoid diagnostic. BMC Infect Dis. 2010; 10: 45.
  5. Andrews JR, Ryan ET. Diagnostics for invasive Salmonella infections: Current challenges and future directions. Vaccine. 2015; Suppl 3: C8-15.
  6. Song Y, Huang YY, Liu X, Zhang X, Ferrari M, Qin L. Point-of-care technologies for molecular diagnostics using a drop of blood. Trends Biotechnol. 2014; 32: 132–139.
  7. Bakr WM, El Attar LA, Ashour MS, El Toukhy AM. The dilemma of widal test - which brand to use? A study of four different widal brands: a cross sectional comparative study. Ann Clin Microbiol Antimicrob. 2011; 10: 7.
  8. Tam FC, Lim PL. The TUBEX typhoid test based on particle-inhibition immunoassay detects IgM but not IgG anti-O9 antibodies. J Immunol Methods. 2003; 282: 83–91.
  9. Olsen SJ, Pruckler J, Bibb W, Nguyen TMT, Tran MT, Nguyen TM, et al. Evaluation of rapid diagnostic tests for typhoid fever. J Clin Microbiol. 2004; 42: 1885–1889.
  10. Rahman M, Siddique AK, Tam FC-H, Sharmin S, Rashid H, Igbal A, et al. Rapid detection of early typhoid fever in endemic community children by the TUBEX® O9-antibody test. Diagn Microbiol Infect Dis. 2007; 58: 275–281.
  11. Wijedoru L, Mallet S, Parry CM. Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever. Cochrane Database of Systematic Reviews 2017, Issue 5. Art. No.: CD008892.
  12. Lim PL, Tam FC, Cheong YM, Jegathesan M. One-step 2-minute test to detect typhoid-specific antibodies based on particle separation in tubes. J Clin Microbiol. 1998; 36: 2271–2278.
  13. Yan M, Tam FCH, Kan B, Lim PL. Combined Rapid (TUBEX) Test for Typhoid-Paratyphoid A Fever Based on Strong Anti-O12 Response: Design and Critical Assessment of Sensitivity. PLoS One. 2011; 6: e24743.
  14. Departemen Kesehatan Republik Indonesia. Profil Kesehatan Indonesia. Jakarta: Departemen Kesehatan Republik Indonesia; 2001.
  15. Porter KR, Beckett CG, Kosasih H, Tan RI, Alisjahbana B, Rudiman PI, et al. Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am J Trop Med Hyg. 2005; 72: 60–66.
  16. Kosasih H, Alisjahbana B, Nurhayati, de Mast Q, Rudiman IF, Widjaja S, et al. The epidemiology, virology and clinical findings of dengue virus infections in a cohort of Indonesian adults in western Java. PLoS Negl Trop Dis. 2016; 10: e0004390.
  17. Punjabi NH, Taylor WRJ, Murphy GS, Purwaningsih S, Picarima H, Sisson J, et al. Etiology of acute, non-malaria, febrile illnesses in Jayapura, northeastern Papua, Indonesia. Am J Trop Med Hyg. 2012; 86: 46–51.
  18. Vollaard AM, Ali S, Widjaja S, Asten HAGH van, Visser LG, Surjadi C, et al. Identification of typhoid fever and paratyphoid fever cases at presentation in outpatient clinics in Jakarta, Indonesia. Trans R Soc Trop Med Hyg. 2005; 99: 440–450.
  19. Tam FCH, Wang M, Dong B, Leung DTM, Ma CH, Lim PL. New rapid test for paratyphoid a fever: usefulness, cross-detection, and solution. Diagn Microbiol Infect Dis. 2008; 62: 142–150.
  20. Kuvandik C, Karaoglan I, Namiduru M, Baydar I. Predictive value of clinical and laboratory findings in the diagnosis of the enteric fever. New Microbiol. 2009; 32: 25–30.
  21. Anabire NG, Aryee PA, Helegbe GK. Hematological abnormalities in patients with malaria and typhoid in Tamale Metropolis of Ghana. BMC Res Notes. 2018; 11:353.
  22. Alugupalli KR, Leong JM, Woodland RT, Muramatsu M, Honjo T, Gerstein RM. B1b Lymphocytes Confer T Cell-Independent Long-Lasting Immunity. Immunity. 2004; 21: 379–390.
  23. Strid MA, Dalby T, Molbak K, Krogfelt KA. Kinetics of the human antibody response against Salmonella enterica Serovars Enteritidis and Typhimurium determined by lipopolysaccharide enzyme-linked immunosorbent assay. Clin Vaccine Immunol. 2007;14(6):741-7.
  24. Levine MM, Black RE, Lanata C. Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis. 1982; 146: 724–726.
  25. Gunn JS, Marshall JM, Baker S, Dongol S, Charles RC, Ryan ET. Salmonella chronic carriage: epidemiology, diagnosis and gallbladder persistence. Trends Microbiol. 2014; 22(11): 648-655.

How to Cite

Pranata, I. W. A., Diana, A., Heryanto, M. R., Lukman, N., Kosasih, H., Djauhari, H., Butarbutar, D. P., Widjaja, S., & Alisjahbana, B. (2022). Persistence of anti-Salmonella O9 IgM as measured by Tubex® TF may contribute to the over-diagnosis of typhoid fever in endemic areas. Bali Medical Journal, 11(1), 11–17. https://doi.org/10.15562/bmj.v11i1.3035
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
11

Total
32

Share

Search Panel

I Wayan Adi Pranata
Google Scholar
Pubmed
BMJ Journal

Aly Diana
Google Scholar
Pubmed
BMJ Journal

Marco R Heryanto
Google Scholar
Pubmed
BMJ Journal

Nurhayati Lukman
Google Scholar
Pubmed
BMJ Journal

Herman Kosasih
Google Scholar
Pubmed
BMJ Journal

Hofiya Djauhari
Google Scholar
Pubmed
BMJ Journal

Deni PR Butarbutar
Google Scholar
Pubmed
BMJ Journal

Susana Widjaja
Google Scholar
Pubmed
BMJ Journal

Bachti Alisjahbana
Google Scholar
Pubmed
BMJ Journal